AG真人官方

Ingredion insider David Eric Seip, SVP, Global Ops and CSCO, was allocated 8.822 phantom stock units under the company鈥檚 SERP on 08/15/2025. The filing shows a reported price of $125.93 per share used to value the award and lists 9,073.8871 shares as the amount beneficially owned by the reporting person following the transaction. The filing is a Form 4 disclosing a non-cash, phantom stock allocation that represents the right to receive one share of common stock per unit.

James P. Zallie, President and CEO and a director of Ingredion Inc. (INGR), reported transactions on 08/12/2025 showing the exercise of employee stock options and a contemporaneous sale of common stock. The filing discloses option exercises of 96,316 and 128,522 shares with exercise prices of $91.85 and $88.35, respectively, and a sale of 36,287 shares at a weighted average price of $126.523 (prices ranged $126.50鈥�$126.60).

The Form 4 notes that 11,677.519 and 17,183.160 shares were withheld to pay applicable taxes from two reported transactions, with the remainder of withheld share amounts used to cover exercise prices (81,634 and 106,917 reported in those line items). The statement was signed by attorney-in-fact Michael N. Levy on 08/14/2025.

Ingredion's Form 144 notifies a proposed sale of 36,287 shares of common stock on the NYSE with an aggregate market value of $4,591,152.89. The filing lists 64,180,890 shares outstanding, and the sale is scheduled approximately for 08/12/2025 through Fidelity Brokerage Services LLC.

The securities were acquired the same day by stock option exercise from the issuer, with payment in cash. The filer reports no securities sold in the past three months and includes the standard representation that no material nonpublic information is known to the selling person.

Ingredion reported mixed results for the quarter and year-to-date periods. Net sales were $1,833 million in Q2 2025 (down 2% year-over-year) and $3,646 million year-to-date (down 3%). Gross profit rose to $477 million in Q2 and $943 million year-to-date as raw material and input costs fell faster than sales, lifting gross margin to 26% year-to-date from 23% a year earlier. Operating income increased to $271 million in Q2 and $547 million year-to-date, a 21% year-over-year rise. Net income attributable to Ingredion was $196 million in Q2 and $393 million year-to-date; diluted EPS were $2.99 and $5.99, respectively.

Liquidity remained substantial with $861 million of cash and $3.7 billion of total available liquidity, while total debt stood at $1.8 billion with most maturities beyond 2026. Cash provided by operating activities declined to $262 million year-to-date from $521 million due to a $250 million working capital increase driven by higher accounts receivable. The company invested $19 million for a 49% stake in the Agrana joint venture, repurchased 409 thousand shares for $55 million year-to-date, and increased its quarterly dividend to $0.80 per share.

Ingredion Inc. (INGR) 鈥� Form 144 filing: Director/officer Larry Fernandes has filed notice of intent to sell 850 common shares through Fidelity Brokerage on or after 04 Aug 2025. At the stated aggregate market value of $109,131.50, the implied share price is roughly $128.39. The proposed sale represents less than 0.002% of the 64.3 million shares outstanding and therefore is immaterial to the company鈥檚 float.

The shares were acquired via restricted-stock vesting on 11 Feb 2025; no cash was paid because the grant was compensation. In the preceding three months Fernandes sold 360 shares for $49,330.80 (鈮� $137.03 per share). No other sales are disclosed in the notice. By signing the form, the filer affirms no undisclosed material adverse information and acknowledges Rule 10b5-1 obligations.

While insider sales can occasionally foreshadow sentiment shifts, the low volume and routine nature of this transaction suggest minimal market impact. Investors may nevertheless monitor future filings for any acceleration in selling activity.